AireHealth Weathered A Global Pandemic by Putting Early Adoption and Co-Creation Strategies to the Test
A Successful Pivot to Support Pandemic Relief Efforts was Made Easier with COIQ and Legacy DNA
When AireHealth was looking to develop an early adoption strategy for their next generation portable nebulizer, they turned to COIQ’s Dr. Roxie and Legacy DNA’s Commercialization of Innovation expertise. Over the next year, the company grew and gained traction in the market – then COVID-19 hit. While many businesses struggled, AireHealth utilized their newly acquired early adoption strategies to identify a pivot that would help aid in the treatment of COVID-19 patients and help the company weather the pandemic’s global effects.
In this success story, find out how COIQ and Legacy DNA worked with AireHealth to build a market strategy specifically tailored to early adopters and provide them with the key components necessary for a successful pivot when it was needed most.
Download the AireHealth Success Story to read how this digital pioneer utilized COIQ and Legacy DNA strategies to survive and thrive in the midst of a global pandemic.